在接受腹腔透析的患者中Roxadustat的有效性和安全性:对四项第三阶段研究的综合分析
Danilo Fliser1, Sunil Bhandari2, Alberto Ortiz3
1Saarland University Medical Center, 66424 Homburg, Germany.
Journal of clinical medicine
|November 27, 2024
概括
罗沙杜沙特在患有慢性脏病的腹腔透析患者的贫血中显示出与红色素形成刺激剂 (ESAs) 相比的非劣势性. 这种口服治疗显示稳定的剂量和可比的安全性,为ESA提供了有效的替代品.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 贫血是慢性病 (CKD) 患者的常见并发症.
- 罗克萨杜沙特是一种口服缺氧诱导因子酸酶抑制剂,已批准用于治疗慢性病的贫血.
- 在腹腔透析 (PD) 患者中,对罗沙沙斯塔特与肠道红色素形成刺激剂 (ESA) 的比较至关重要.
研究的目的:
- 评估与ESA相比,roxadustat在患有PD的贫血慢性病患者中的疗效和安全性.
- 评估roxadustat和ESA组中的血红蛋白水平和治疗结果.
主要方法:
- 综合分析了四项第三阶段,多中心,随机,开放标签,活性比较器研究 (PYRENEES,SIERRAS,HIMALAYAS,ROCKIES).
- 主要终点包括血红蛋白在28-36周 (没有救援) 和28-52周 (有或没有救援) 的基线变化.
- 收集和分析了安全数据,包括不良事件和心血管结果.
主要成果:
- 在血红蛋白校正和维护方面,Roxadustat实现了对ESA的非劣势.
- 罗沙杜沙特呈现出稳定的平均每周剂量,而ESA剂量随着时间的推移而增加.
- 较少的roxadustat患者需要补充铁或救援疗法;他们还显示LDL胆固醇水平有所改善. 安全性概况相似,主要心血管不良事件的危险比率和死亡率低于1.
结论:
- 罗沙杜沙特在治疗慢性病患者的贫血方面与ESA无差.
- 罗沙杜沙特提供稳定的剂量和可比的安全性.
- 罗沙杜沙特 (Roxadustat) 为贫血PD患者提供了一个可行的口服治疗选择.
相关概念视频
Renal Failure: Dose Adjustments
64
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
64
Renal Drug Excretion: Tubular Secretion
138
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
138
Dialysis
269
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
269
Renal Drug Excretion: Tubular Reabsorption
105
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
105
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
136
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
136
Factors Affecting Renal Clearance: Renal Impairment
54
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
54


